The mortality rate for genitourinary system diseases among Brazilian women is forecasted to rise consistently from 48.5 in 2024 to 55.5 per 100,000 by 2028, indicating a persistent upward trend. Compared to the estimated 47.0 rate in 2023, the rate in 2024 reflects a 3.19% increase. This escalation continues at a consistent annual growth rate of approximately 2.77% (CAGR) over the five-year forecast period.
Looking ahead, it will be crucial to monitor factors such as healthcare access, preventive care, and advancements in medical treatment affecting these conditions. Public health interventions may need to intensify in tandem with the aging population in Brazil, which can contribute to the observed trend.
